Learning resource · Teaching note

Experiential Dynamic Therapies

Prepared by MindFrame Editorial

2026

Purpose

An evidence synthesis object reviewing a 2025 systematic review and meta-analysis update on affect-focused, experiential dynamic therapies, an active-emotion-processing branch of the psychodynamic tradition.

Psychology Lens

What the work portrays

This object summarizes current evidence for experiential dynamic therapies, a family of short-term, affect-focused psychodynamic approaches that actively work with emotional experiencing rather than relying primarily on interpretation or insight alone.

Clinical & psychological context

Lilliengren and colleagues' 2025 ten-year systematic review and meta-analysis update in Clinical Psychology & Psychotherapy, synthesizing 57 randomized controlled trials with 4,330 participants across Western and non-Western countries, found substantial effects for experiential dynamic therapies compared with inactive controls, while flagging important heterogeneity across studies and cautioning that comparisons with active treatments require careful interpretation.

Representation note

MindFrame highlights the heterogeneity caveat prominently: 'large effects versus inactive controls' is a genuine and meaningful finding, but it is a different and weaker claim than showing superiority over other active, bona fide therapies, and viewers should not treat this evidence as settling which therapy is most effective overall.

Themes

Concepts

Therapies & interventions

Study Mode

Watch / read → Observe → Reflect → Discuss

What to observe before interpreting

  • The difference between a therapy outperforming an inactive control (waitlist, treatment-as-usual) and outperforming another active treatment
  • What 'affect-focused' or 'experiential' adds to a psychodynamic approach compared with a more purely interpretive style
  • Why 57 trials showing 'important heterogeneity' is a meaningfully qualified finding rather than a simple, uniform result

Discussion questions

  • Why does comparing a therapy to an inactive control tell us less than comparing it to another active treatment?
  • What might 'important heterogeneity' across 57 trials suggest about who these therapies work best for?
  • How does an emphasis on directly working with emotional experience distinguish this therapy family from more classically interpretive psychodynamic therapy?

Sources

A listed source is a traceable reference; it should not be assumed to support every statement on this page unless the claim has been individually reviewed.

Review status

Identity: Pending legacy review · Psychology annotation: Pending legacy review · Source support: Pending legacy review · Rights: Metadata only

Legacy pilot record retained for continuity; publication status does not imply independent verification of every identity, source or psychological claim.